Patent · US Active

Conjugate constructs, delivery, and use for treatment of disease

US8575126B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Inventors

Key dates

Filing dateJun 27, 2012
Grant dateNov 5, 2013
Priority date
Expiry dateJun 27, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3233
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical formulations of antisense peptide-conjugated phosphorodiamidate morpholino olgomers and methods of use for treatment of apicomplexan infections are disclosed. The invention is particularly directed to treatment of Toxoplasma gondii infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.